Anna Park

936 total citations
17 papers, 514 citations indexed

About

Anna Park is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Anna Park has authored 17 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Anna Park's work include Monoclonal and Polyclonal Antibodies Research (14 papers), Glycosylation and Glycoproteins Research (7 papers) and HER2/EGFR in Cancer Research (5 papers). Anna Park is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (14 papers), Glycosylation and Glycoproteins Research (7 papers) and HER2/EGFR in Cancer Research (5 papers). Anna Park collaborates with scholars based in United States, France and Germany. Anna Park's co-authors include Huawei Qiu, Qun Zhou, Clark Q. Pan, Kerry Culm-Merdek, Scott Estes, Alison McVie‐Wylie, André Roy, Tim Edmunds, Srinivas Shankara and James E. Stefano and has published in prestigious journals such as Journal of Virology, Endocrinology and Biotechnology and Bioengineering.

In The Last Decade

Anna Park

14 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Park United States 10 392 320 166 101 68 17 514
Meritxell Galindo Casas United States 7 270 0.7× 275 0.9× 191 1.2× 85 0.8× 29 0.4× 9 511
Hanne Merritt United States 8 255 0.7× 418 1.3× 135 0.8× 63 0.6× 43 0.6× 13 532
Whitney Shatz-Binder United States 13 354 0.9× 388 1.2× 76 0.5× 113 1.1× 23 0.3× 21 592
Thomas Arroll United States 8 284 0.7× 291 0.9× 81 0.5× 145 1.4× 18 0.3× 9 492
Vani Lakshminarayanan United States 7 165 0.4× 352 1.1× 76 0.5× 255 2.5× 147 2.2× 11 475
Bhaswati Barat United States 10 200 0.5× 223 0.7× 137 0.8× 98 1.0× 26 0.4× 17 426
Natasha Ann Pereira Singapore 8 203 0.5× 409 1.3× 114 0.7× 216 2.1× 20 0.3× 8 592
Radmila Moudry Switzerland 6 455 1.2× 534 1.7× 80 0.5× 243 2.4× 52 0.8× 10 701
Ina Theobald Germany 6 197 0.5× 336 1.1× 66 0.4× 66 0.7× 23 0.3× 7 459
Reiko Kuni‐Kamochi Japan 6 536 1.4× 611 1.9× 68 0.4× 242 2.4× 35 0.5× 6 711

Countries citing papers authored by Anna Park

Since Specialization
Citations

This map shows the geographic impact of Anna Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Park more than expected).

Fields of papers citing papers by Anna Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Park. The network helps show where Anna Park may publish in the future.

Co-authorship network of co-authors of Anna Park

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Park. A scholar is included among the top collaborators of Anna Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Park. Anna Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Mukai, Kaori, Xiaohua Liu, Ekaterina Boudanova, et al.. (2024). Targeted protein degradation through site-specific antibody conjugation with mannose 6-phosphate glycan. mAbs. 16(1). 2415333–2415333. 3 indexed citations
2.
Witte, Wilhelmus E. A. de, et al.. (2023). Mechanistic incorporation of FcRn binding in plasma and endosomes in a whole body PBPK model for large molecules. Journal of Pharmacokinetics and Pharmacodynamics. 50(3). 229–241. 6 indexed citations
4.
Lee, Jaehyeon, et al.. (2021). Application of an integrated computational antibody engineering platform to design SARS-CoV-2 neutralizers. PubMed. 4(2). 109–122. 9 indexed citations
5.
Zhou, Qun, Josephine Kyazike, Ekaterina Boudanova, et al.. (2021). Site-Specific Antibody Conjugation to Engineered Double Cysteine Residues. Pharmaceuticals. 14(7). 672–672. 17 indexed citations
6.
Zhang, Ruijun, Ponraj Prabakaran, Xiaocong Yu, et al.. (2021). A platform-agnostic, function first-based antibody discovery strategy using plasmid-free mammalian expression of antibodies. mAbs. 13(1). 5 indexed citations
7.
Zhou, Qun, Ekaterina Boudanova, Jochen Beninga, et al.. (2020). Engineered Fc-glycosylation switch to eliminate antibody effector function. mAbs. 12(1). 1814583–1814583. 11 indexed citations
8.
Park, Anna, et al.. (2020). RECEPTOR-MEDIATED ENDOCYTOSIS MODELING OF ANTIBODY-DRUG CONJUGATES TO THE RELEASED PAYLOAD WITHIN THE INTRACELLULAR SPACE CONSIDERING TARGET ANTIGEN EXPRESSION LEVELS. Journal of Applied Analysis & Computation. 10(5). 1848–1868. 1 indexed citations
9.
Boudanova, Ekaterina, Anna Park, Olivier Pasquier, et al.. (2019). Antibody Fc engineering for enhanced neonatal Fc receptor binding and prolonged circulation half-life. mAbs. 11(7). 1276–1288. 73 indexed citations
11.
Lord, Dana M., et al.. (2018). Structure-based engineering to restore high affinity binding of an isoform-selective anti-TGFβ1 antibody. mAbs. 10(3). 444–452. 9 indexed citations
12.
Park, Kyoung Ho, et al.. (2015). A Case of Inhalation Burn-Induced Extensive Tracheal Inflammatory Crust Removed by Ventilating Bronchoscopy under Tracheostomy and Extracorporeal Membrane Oxygenation. Korean Journal of Otorhinolaryngology - Head and Neck Surgery. 58(12). 882–882.
13.
Zhou, Qun, James E. Stefano, Josephine Kyazike, et al.. (2014). Site-Specific Antibody–Drug Conjugation through Glycoengineering. Bioconjugate Chemistry. 25(3). 510–520. 177 indexed citations
14.
Stefano, James E., et al.. (2013). Micro- and Mid-Scale Maleimide-Based Conjugation of Cytotoxic Drugs to Antibody Hinge Region Thiols for Tumor Targeting. Methods in molecular biology. 1045. 145–171. 9 indexed citations
15.
Qiu, Huawei, Ekaterina Boudanova, Anna Park, et al.. (2013). Site-Specific PEGylation of Human Thyroid Stimulating Hormone to Prolong Duration of Action. Bioconjugate Chemistry. 24(3). 408–418. 12 indexed citations
16.
Park, Anna, Lihui Hou, Julie Bird, et al.. (2013). Carbohydrate-Mediated Polyethylene Glycol Conjugation of TSH Improves Its Pharmacological Properties. Endocrinology. 154(3). 1373–1383. 11 indexed citations
17.
Zhou, Qun, Srinivas Shankara, André Roy, et al.. (2007). Development of a simple and rapid method for producing non‐fucosylated oligomannose containing antibodies with increased effector function. Biotechnology and Bioengineering. 99(3). 652–665. 149 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026